Search Results - "Gregorič Kramberger, Milica"

Mechanisms of tremor-modulating effects of primidone and propranolol in essential tremor by Vogelnik Žakelj, Katarina, Prezelj, Neža, Gregorič Kramberger, Milica, Kojović, Maja

“…Primidone and propranolol are primary treatments for essential tremor, however the exact mechanisms underlying their efficacy are not fully elucidated…”
Get full text

The Association of Selected GWAS Reported AD Risk Loci with CSF Biomarker Levels and Cognitive Decline in Slovenian Patients by Vogrinc, David, Gregorič Kramberger, Milica, Emeršič, Andreja, Čučnik, Saša, Goričar, Katja, Dolžan, Vita

“…Alzheimer’s disease (AD) is the most common neurodegenerative disease, with a complex genetic background. Apart from rare, familial cases, a combination of…”
Get full text

Dopaminergic Pathway Genes Influence Adverse Events Related to Dopaminergic Treatment in Parkinson's Disease by Redenšek, Sara, Flisar, Dušan, Kojović, Maja, Gregorič Kramberger, Milica, Georgiev, Dejan, Pirtošek, Zvezdan, Trošt, Maja, Dolžan, Vita

“…Dopaminergic pathway is the most disrupted pathway in the pathogenesis of Parkinson's disease. Several studies reported associations of dopaminergic genes with…”
Get full text

Genetic Polymorphisms in Oxidative Stress and Inflammatory Pathways as Potential Biomarkers in Alzheimer's Disease and Dementia by Vogrinc, David, Gregorič Kramberger, Milica, Emeršič, Andreja, Čučnik, Saša, Goričar, Katja, Dolžan, Vita

“…Oxidative stress and neuroinflammation are important processes involved in Alzheimer's disease (AD) and mild cognitive impairment (MCI). Numerous risk factors,…”
Get full text

Genetic variability of inflammation and oxidative stress genes does not play a major role in the occurrence of adverse events of dopaminergic treatment in Parkinson's disease by Redenšek, Sara, Flisar, Dušan, Kojović, Maja, Kramberger, Milica Gregorič, Georgiev, Dejan, Pirtošek, Zvezdan, Trošt, Maja, Dolžan, Vita

“…Inflammation and oxidative stress are recognized as important contributors to Parkinson's disease pathogenesis. As such, genetic variability in these pathways…”
Get full text

Investigation of Paraoxonase-1 Genotype and Enzyme-Kinetic Parameters in the Context of Cognitive Impairment in Parkinson's Disease by Petrič, Boštjan, Redenšek Trampuž, Sara, Dolžan, Vita, Gregorič Kramberger, Milica, Trošt, Maja, Maraković, Nikola, Goličnik, Marko, Bavec, Aljoša

“…Cognitive impairment is a common non-motor symptom of Parkinson's disease (PD), which often progresses to PD dementia. PD patients with and without dementia…”
Get full text

Head‐to‐head comparison of clinical performance of CSF phospho‐tau T181 and T217 biomarkers for Alzheimer's disease diagnosis by Karikari, Thomas K., Emeršič, Andreja, Vrillon, Agathe, Lantero‐Rodriguez, Juan, Ashton, Nicholas J., Kramberger, Milica Gregorič, Dumurgier, Julien, Hourregue, Claire, Čučnik, Saša, Brinkmalm, Gunnar, Rot, Uroš, Zetterberg, Henrik, Paquet, Claire, Blennow, Kaj

“…Introduction Phosphorylated tau (p‐tau) in cerebrospinal fluid (CSF) is an established Alzheimer's disease (AD) biomarker. Novel immunoassays targeting…”
Get full text

Kognitivne motnje pri bolnikih s sladkorno boleznijo tipa 2 by Špeh, Andreja, Šatej, Nika, Janež, Andrej, Gregorič Kramberger, Milica

“…Prevalenci sladkorne bolezni in demence v zadnjih letih naraščata, bolezni pa si delita številne dejavnike tveganja, kot so hipertenzija, dislipidemija,…”
Get full text

N-terminal and mid-region tau fragments as fluid biomarkers in neurological diseases by Snellman, Anniina, Lantero-Rodriguez, Juan, Emeršič, Andreja, Vrillon, Agathe, Karikari, Thomas K, Ashton, Nicholas J, Gregorič Kramberger, Milica, Čučnik, Saša, Paquet, Claire, Rot, Uroš, Zetterberg, Henrik, Blennow, Kaj

“…Brain-derived tau secreted into CSF and blood consists of different N-terminal and mid-domain fragments, which may have a differential temporal course and…”
Get full text

Plasma p-tau212 antemortem diagnostic performance and prediction of autopsy verification of Alzheimer’s disease neuropathology by Kac, Przemysław R., González-Ortiz, Fernando, Emeršič, Andreja, Dulewicz, Maciej, Koutarapu, Srinivas, Turton, Michael, An, Yang, Smirnov, Denis, Kulczyńska-Przybik, Agnieszka, Varma, Vijay R., Ashton, Nicholas J., Montoliu-Gaya, Laia, Camporesi, Elena, Winkel, Izabela, Paradowski, Bogusław, Moghekar, Abhay, Troncoso, Juan C., Lashley, Tammaryn, Brinkmalm, Gunnar, Resnick, Susan M., Mroczko, Barbara, Kvartsberg, Hlin, Gregorič Kramberger, Milica, Hanrieder, Jörg, Čučnik, Saša, Harrison, Peter, Zetterberg, Henrik, Lewczuk, Piotr, Thambisetty, Madhav, Rot, Uroš, Galasko, Douglas, Blennow, Kaj, Karikari, Thomas K.

“…Blood phosphorylated tau (p-tau) biomarkers, including p-tau217, show high associations with Alzheimer’s disease (AD) neuropathologic change and clinical…”
Get full text

Slovenian Memory Clinic Organization with the Introduction of Potential New Alzheimer's Disease Treatment by Zupanic, Eva, Emersic, Andreja, Wimo, Anders, Winblad, Bengt, Speh, Andreja, Kramberger, Milica Gregoric

“…Slovenia, situated in Central Europe with a population of 2.1 million, has an estimated 44,278 individuals with mild cognitive impairment due to Alzheimer's…”
Get more information

Cerebrospinal fluid p‐tau181, 217, and 231 in definite Creutzfeldt–Jakob disease with and without concomitant pathologies by Emeršič, Andreja, Ashton, Nicholas J., Vrillon, Agathe, Lantero‐Rodriguez, Juan, Mlakar, Jernej, Gregorič Kramberger, Milica, Gonzalez‐Ortiz, Fernando, Kac, Przemysław R., Dulewicz, Maciej, Hanrieder, Jörg, Vanmechelen, Eugeen, Rot, Uroš, Zetterberg, Henrik, Karikari, Thomas K., Čučnik, Saša, Blennow, Kaj

“…INTRODUCTION The established cerebrospinal fluid (CSF) phosphorylated tau181 (p‐tau181) may not reliably reflect concomitant Alzheimer's disease (AD) and…”
Get full text

The relationship between change in cardiovascular health and rate of cognitive decline: a population-based study by Speh, Andreja, Kramberger, Milica Gregorič, Winblad, Bengt, Bäckman, Lars, Chengxuan, Qiu, Laukka, Erika Jonsson

“…Vascular risk factors in midlife have been associated with accelerated age-related cognitive decline. However, associations with old-age cardiovascular health…”
Get full text

Genetic variability of incretin receptors affects the occurrence of neurodegenerative diseases and their characteristics by Vogrinc, David, Redenšek Trampuž, Sara, Blagus, Tanja, Trošt, Maja, Gregorič Kramberger, Milica, Emeršič, Andreja, Čučnik, Saša, Goričar, Katja, Dolžan, Vita

“…Alzheimer's disease (AD) and Parkinson's disease (PD) are the most common neurodegenerative diseases. Their treatment options are rather limited, and no…”
Get full text

Cost of diagnosing and treating cognitive complaints: One-year cost-evaluation study in a patient cohort from a Slovenian memory clinic by Županič, Eva, Wimo, Anders, Winblad, Bengt, Kramberger, Milica Gregorič

“…Dementias present a global health challenge and give rise to significant economic costs. This study aims to evaluate the economic impact of one-year outpatient…”
Get full text

Feasibility and usability of remote monitoring in Alzheimer's disease by Muurling, Marijn, de Boer, Casper, Hinds, Chris, Atreya, Alankar, Doherty, Aiden, Alepopoulos, Vasilis, Curcic, Jelena, Brem, Anna-Katharine, Conde, Pauline, Kuruppu, Sajini, Morató, Xavier, Saletti, Valentina, Galluzzi, Samantha, Vilarino Luis, Estefania, Cardoso, Sandra, Stukelj, Tina, Kramberger, Milica Gregorič, Roik, Dora, Koychev, Ivan, Hopøy, Ann-Cecilie, Schwertner, Emilia, Gkioka, Mara, Aarsland, Dag, Visser, Pieter Jelle

“…Remote monitoring technologies (RMTs) can measure cognitive and functional decline objectively at-home, and offer opportunities to measure passively and…”
Get full text

Vozniške zmožnosti pri demenci in parkinsonizmu by Gregorič Kramberger, Milica, Trošt, Maja, Špeh, Andreja, Franko, Alenka, Kavčič, Vojko

“…Samostojna vožnja avtomobila posamezniku omogoča neodvisnost in dejavno vključenost v družbo. Predstavlja kompleksno dejavnost, ki zahteva uporabo kognitivnih,…”
Get full text

Costs of diagnosing early Alzheimer's disease in three European memory clinic settings: Results from the precision medicine in Alzheimer's disease project by Wimo, Anders, Kirsebom, Bjørn‐Eivind, Timón‐Reina, Santiago, Vromen, Ellen, Selnes, Per, Bon, Jaka, Emersic, Andreja, Kramberger, Milica Gregoric, Speh, Andreja, Visser, Pieter Jelle, Winblad, Bengt, Fladby, Tormod

“…Objectives The implementation of disease‐modifying treatments for Alzheimer's Disease (AD) will require cost‐effective diagnostic processes. As part of The…”
Get full text

Parkinson's disease dementia: clinical correlates of brain spect perfusion and treatment by Kramberger, Milica Gregoric, Stukovnik, Vita, Cus, Anja, Repovs, Grega, Tomse, Petra, Meglic, Nuska Pecaric, Garasević, Zdenko, Jensterle, Joze, Pirtosek, Zvezdan

“…The main clinical feature of dementia in Parkinson's disease is a dysexecutive syndrome. The neuropathology of PD dementia (PDD) is likely multifactorial and…”
Get full text

Zolpidem withdrawal status dystonicus in the patient with advanced Parkinson's disease by Kojović, Maja, Gregorič Kramberger, Milica

Get full text